Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€43.15

€43.15

3.570%
1.5
3.570%
-
 
01.03.24 / Tradegate WKN: STRA55 / Name: Stratec / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Stratec SE Stock

Stratec SE dominated the market today, gaining €1.50 (3.570%).
For the coming years our community has positive and negative things to say abot the Stratec SE stock. Criterium "Unique positioning" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.

Pros and Cons of Stratec SE in the next few years

Pros
?
B****
?
C******** o* t** e**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Stratec SE vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Stratec SE 3.570% -2.376% 1.649% -43.815% -5.991% -63.800% -26.864%
Eckert & Ziegler Strahlen- und Medizintechnik AG 0.380% 1.094% -7.525% -19.774% 2.854% -27.254% 96.397%
Paul Hartmann AG -1.320% 3.182% 3.182% -2.575% 10.732% -40.263% -
Geratherm Medical AG -0.960% -2.778% -5.405% -35.819% -3.670% -56.612% -43.243%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-18

In general, the financials of Stratec from the Healthcare Equipment & Supplies industry appear to be stable, experiencing growth in some areas while also facing certain challenges in others. The company has exhibited an upward trend in asset accumulation over the years, with total assets growing from 331.9 million EUR in 2020 to 397.5 million EUR in 2022. Additionally, Stratec has managed to maintain a healthy net income throughout this period.

Growth in Total Assets and Revenues: The total assets have seen growth over the years, increasing from 331.9 million EUR in 2020 to 397.5 million EUR in 2022. This is an indication that the company is consistently investing and expanding. Furthermore, Stratec experienced an increase in total revenues, from 250 million EUR in 2020 to 274.6 million EUR in 2022, reflecting positively on the company's financial performance.

Positive Net Income: Stratec has maintained a positive net income over the years, with the highest figure reached in 2021 at 39.9 million EUR. This shows that the company is profitable, which can help build investor confidence.

Comments

systinvest bought the security Stratec SE in his wikifolio Aktienwertselektion mit System.
Show more

Prediction Buy
Perf. (%) 30.79%
Target price 53.240
Change
Ends at 08.04.19

(Laufzeit überschritten)
Show more

Prediction Buy
Perf. (%) 30.79%
Target price 53.240
Change
Ends at 08.04.19

(Laufzeit überschritten)
Show more

News

EQS-News: STRATEC TO PARTICIPATE IN THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24071/375px-Stratec-Biomedical-Logo.svg.png
EQS-News: STRATEC TO PARTICIPATE IN THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
EQS-News: STRATEC TO PARTICIPATE IN THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
EQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24071/375px-Stratec-Biomedical-Logo.svg.png
EQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023
EQS-News: STRATEC REPORTS RESULTS FOR FIRST NINE MONTHS OF 2023